Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy
1997

Prognostic Factors in Advanced Hodgkin's Disease

Sample size: 453 publication Evidence: moderate

Author Information

Author(s): SM Lee, JA Radford, WDJ Ryder, CD Collins, DP Deakin, D Crowther

Primary Institution: Christie Hospital NHS Trust

Hypothesis

Can a very high-risk group of patients with advanced Hodgkin's disease be identified based on presenting characteristics?

Conclusion

No sufficiently high-risk group of patients with Hodgkin's disease was identified for whom high-dose chemotherapy could be recommended as part of primary treatment.

Supporting Evidence

  • The study analyzed 453 patients who did not progress in the first 6 months after starting chemotherapy.
  • The worst prognostic group had a freedom from progression rate of 57% at 5 years.
  • Four other prognostic indices were evaluated but none were successful in identifying a very high-risk group.

Takeaway

The study looked at patients with advanced Hodgkin's disease to see if some were at high risk of getting worse, but it found that most patients do well with standard treatment.

Methodology

Data from 453 patients aged under 60 years with advanced Hodgkin's disease were analyzed using Cox regression to evaluate prognostic factors.

Limitations

The study could not identify a high-risk group for high-dose chemotherapy, and some data were missing for key prognostic variables.

Participant Demographics

Patients were aged under 60 years and included both males and females.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication